Regulatory T-cell depletion does not prevent emergence of new CD25⁺ FOXP3⁺ lymphocytes after antigen stimulation in culture

References

• Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151–64
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531–62
   PubMed Web of Science ®Google Scholar
• Godfrey VL, Rouse BT, Wilkinson JE. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol 1994; 145: 281–6
   PubMed Web of Science ®Google Scholar
• Blair PJ, Bultman SJ, Haas JC, et al. CD4+CD8− T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994; 153: 3764–74
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057–61
   PubMed Web of Science ®Google Scholar
• Watanabe N, Wang YH, Lee HK, et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436: 1181–5
   PubMed Web of Science ®Google Scholar
• Schubert LA, Jeffery E, Zhang Y, et al. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001; 276: 37672–9
   PubMed Web of Science ®Google Scholar
• Clark FJ, Gregg R, Piper K, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood 2004; 103: 2410–6
   PubMed Web of Science ®Google Scholar
• Stanzani M, Martins SL, Saliba RM, et al. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood 2004; 103: 1140–6
   PubMed Web of Science ®Google Scholar
• Zhang J, Markovic-Plese S, Lacet B, et al. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179: 973–84
   PubMed Web of Science ®Google Scholar
• Mutis T, Aarts-Riemens T, Verdonck LF. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions. Haematologica 2005; 90: 1389–95
   PubMed Web of Science ®Google Scholar
• Tree TI, Roep BO, Peakman M. A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. Ann NY Acad Sci 2006; 1079: 9–18
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005; 54: 92–9
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330–6
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, et al. An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 337–42
   PubMed Web of Science ®Google Scholar
• Venken K, Hellings N, Hensen K, et al. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J Neurosci Res 2006; 83: 1432–46
   PubMed Web of Science ®Google Scholar
• Viglietta V, Baecher-Allan C, Weiner HL, et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971–9
   PubMed Web of Science ®Google Scholar
• Kriegel MA, Lohmann T, Gabler C, et al. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004; 199: 1285–91
   PubMed Web of Science ®Google Scholar
• Powell DJ, Jr, Parker LL, Rosenberg SA. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. J Immunother 2005; 28: 403–11
   PubMed Web of Science ®Google Scholar
• Godfrey WR, Ge YG, Spoden DJ, et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004; 104: 453–61
   PubMed Web of Science ®Google Scholar
• O'Flynn K, Krensky AM, Beverley PC, et al. Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature 1985; 313: 686–7
   PubMed Web of Science ®Google Scholar
• Kanellopoulos JM, De Petris S, Leca G, et al. The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes. Eur J Immunol 1985; 15: 479–86
   PubMed Web of Science ®Google Scholar
• Cantrell D, Davies AA, Londei M, et al. Association of phosphorylation of the T3 antigen with immune activation of T lymphocytes. Nature 1987; 325: 540–2
   PubMed Web of Science ®Google Scholar
• Breitmeyer JB, Daley JF, Levine HB, et al. The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells. J Immunol 1987; 139: 2899–905
   PubMed Web of Science ®Google Scholar
• Choi YW, Kotzin B, Herron L, et al. Interaction of Staphylococcus aureus toxin ‘superantigens’ with human T cells. Proc Natl Acad Sci USA 1989; 86: 8941–5
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Douek DC. Flow cytometric analysis of human antigen-specific T-cell proliferation. Methods Cell Biol 2004; 75: 481–96
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Solomon SR, Shenoy A, et al. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. J Immunother 2006; 29: 365–6; 436–43
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Brummendorf TH, Kirby M, et al. CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis. Leuk Res 2001; 25: 699–708
   PubMed Web of Science ®Google Scholar
• Perfetto SP, Chattopadhyay PK, Lamoreaux L, et al. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J Immunol Methods 2006; 313: 199–208
   PubMed Web of Science ®Google Scholar
• Scheinberg P, Melenhorst JJ, Hill BJ, et al. The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements. J Immunol Methods 2007; 321: 107–20
   PubMed Web of Science ®Google Scholar
• Douek DC, Betts MR, Brenchley JM, et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 2002; 168: 3099–104
   PubMed Web of Science ®Google Scholar
• Price DA, West SM, Betts MR, et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004; 21: 793–803
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701–11
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693–700
   PubMed Web of Science ®Google Scholar
• Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103: 6659–64
   PubMed Web of Science ®Google Scholar
• Wang J, Ioan-Facsinay A, van der Voort EI, et al. Transient expression of FOXP3 in human activated nonregulatory CD4(+) T cells. Eur J Immunol 2007; 37: 129–38
   PubMed Web of Science ®Google Scholar
• Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345–54
   PubMed Web of Science ®Google Scholar
• Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005; 35: 1681–91
   PubMed Web of Science ®Google Scholar
• Raimondi G, Shufesky WJ, Tokita D, et al. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J Immunol 2006; 176: 2808–16
   PubMed Web of Science ®Google Scholar
• Bruder D, Probst-Kepper M, Westendorf AM, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004; 34: 623–30
   PubMed Web of Science ®Google Scholar
• Boettler T, Spangenberg HC, Neumann-Haefelin C, et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 79: 7860–7
   PubMed Web of Science ®Google Scholar
• Attia P, Powell DJ, Jr, Maker AV, et al. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J Immunother 2006; 29: 208–14
   PubMed Web of Science ®Google Scholar
• Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005; 66: 13–20
   PubMed Web of Science ®Google Scholar
• Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005; 115: 3276–84
   PubMed Web of Science ®Google Scholar
• Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25− T cells. J Clin Invest 2003; 112: 1437–43
   PubMed Web of Science ®Google Scholar
• Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16: 1643–56
   PubMed Web of Science ®Google Scholar
• Wu Y, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006; 126: 375–87
   PubMed Web of Science ®Google Scholar
• Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 2005; 102: 5138–43
   PubMed Web of Science ®Google Scholar
• Chae WJ, Henegariu O, Lee SK, et al. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc Natl Acad Sci USA 2006; 103: 9631–6
   PubMed Web of Science ®Google Scholar
• Gavin MA, Rasmussen JP, Fontenot JD, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007; 445: 771–5
   PubMed Web of Science ®Google Scholar
• Mackenzie DA, Schartner J, Lin J, et al. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem 2007; 282: 9696–702
   PubMed Web of Science ®Google Scholar
• Li L, Godfrey WR, Porter SB, et al. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 2005; 106: 3068–73
   PubMed Web of Science ®Google Scholar
• Godfrey WR, Spoden DJ, Ge YG, et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105: 750–8
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007; 7: 305–10
   PubMed Web of Science ®Google Scholar
• Zinkernagel R. On observing and analyzing disease versus signals. Nat Immunol 2007; 8: 8–10
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM, Hengartner H. On immunity against infections and vaccines: credo 2004. Scand J Immunol 2004; 60: 9–13
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM, Hengartner H. Regulation of the immune response by antigen. Science 2001; 293: 251–3
   PubMed Web of Science ®Google Scholar
• Akbar AN, Vukmanovic-Stejic M, Taams LS, et al. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007; 7: 231–7
   PubMed Web of Science ®Google Scholar